Premier Business Partner

Nolan Propane

Check out our latest Edition!

 

alan blog tli

newswirelogo

  • SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong’s attempt to allow him and his company, NantPharma, to avoid the billion-dollar fraud and breach of contract claims that Sorrento filed against them earlier this year.  Sorrento’s claims relate to the “catch and kill” scheme that Soon-Shiong allegedly orchestrated to keep Sorrento’s promising cancer drug, Cynviloq, off the market in order to preserve Soon-Shiong’s personal financial interest in another competing drug.

  • OMAHA, Neb., Oct. 15, 2019 (GLOBE NEWSWIRE) -- PhaZZer announces that TASER/AXON (AAXN) filed a (now withdrawn) unsupported lawsuit in what appeared to be a last-ditch attempt to stop the PhaZZer Enforcer CEW and cartridges’ entry as the only viable and accepted competitor by US Law Enforcement. It appears that all other competitors have been silenced through litigation using the TASER ‘262 patent; which the USPTO Examiner declared invalid on all claims in its FINAL OFFICE ACTION on April 27th 2018 and AFFIRMED on appeal by Patent Trial And Appeal Board (“PTAB”) on September 27, 2019.  

  • SOUTH SAN FRANCISCO, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune mediated diseases, today announced the pricing of its underwritten public offering of 7,500,000 shares of its common stock at a price to the public of $28.00 per share. The gross proceeds to Principia from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Principia, are expected to be $210 million. Principia has also granted the underwriters a 30-day option to purchase up to 1,125,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares are being offered by Principia. 

  • HONG KONG, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Epiq, a global leader in the legal services industry, announced that acclaimed information governance (IG) expert, Elizabeth Fogerty, will lead the Epiq IG practice across the Asia-Pacific region as the director of strategic relationships and compliance consulting.

  • NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Macrogenics, Inc. (NASDAQ: MGNX), ViewRay, Inc. (NASDAQ: VRAY), Cadence Bancorp (NYSE: CADE), and ProPetro Holding Corp. (NYSE: PUMP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Contact Us

Transportation and Logistics International

150 N. Michigan Ave., Suite 900
Chicago, IL 60601
312.676.1100  312.676.1101

Click here for a full list of contacts.

Latest Edition

Spread The Love

Back To Top